Literature DB >> 8406836

The gene encoding phosphoribosylaminoimidazole carboxylase (ADE2) is essential for growth of Cryptococcus neoformans in cerebrospinal fluid.

J R Perfect1, D L Toffaletti, T H Rude.   

Abstract

A cryptococcal meningitis model in corticosteroid-treated rabbits was used to assess the requirement for the phosphoribosylaminoimidazole gene (ADE2) for virulence of Cryptococcus neoformans. A wild-type strain (H99), an ade2 auxotroph of H99 (M001), and a randomly selected prototrophic transformant of M001 (M001.1c) which had received the cloned ADE2 cDNA copy were inoculated intrathecally into immunosuppressed rabbits. While M001 was avirulent in the central nervous system model, virulence was completely restored to wild-type pathogenicity in the prototrophic transformant. This study identifies the pathogenic importance of an endogenous adenine pathway in this yeast and confirms that purine biosynthesis is a potential target for antifungal therapy. It also demonstrates that the virulence of C. neoformans can be molecularly changed and detected within a clinically relevant animal model.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8406836      PMCID: PMC281178          DOI: 10.1128/iai.61.10.4446-4451.1993

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  43 in total

1.  The effects of biochemical mutation on the virulence of Bacterium typhosum: the virulence of mutants.

Authors:  G A BACON; T W BURROWS; M YATES
Journal:  Br J Exp Pathol       Date:  1950-12

2.  Production of the hexitol D-mannitol by Cryptococcus neoformans in vitro and in rabbits with experimental meningitis.

Authors:  B Wong; J R Perfect; S Beggs; K A Wright
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

3.  The growth of purine mutants of Bacillus anthracis in the body of the mouse.

Authors:  G Ivánovics; E Marjai; A Dobozy
Journal:  J Gen Microbiol       Date:  1968-09

4.  Influence of agglutinating antibody in experimental cryptococcal meningitis.

Authors:  J R Perfect; S D Lang; D T Durack
Journal:  Br J Exp Pathol       Date:  1981-12

5.  Isolation of the URA5 gene from Cryptococcus neoformans var. neoformans and its use as a selective marker for transformation.

Authors:  J C Edman; K J Kwon-Chung
Journal:  Mol Cell Biol       Date:  1990-09       Impact factor: 4.272

6.  Itraconazole therapy for cryptococcal meningitis and cryptococcosis.

Authors:  D W Denning; R M Tucker; L H Hanson; J R Hamilton; D A Stevens
Journal:  Arch Intern Med       Date:  1989-10

7.  Comparison of amphotericin B and N-D-ornithyl amphotericin B methyl ester in experimental cryptococcal meningitis and Candida albicans endocarditis with pyelonephritis.

Authors:  J R Perfect; D T Durack
Journal:  Antimicrob Agents Chemother       Date:  1985-12       Impact factor: 5.191

8.  Decreased virulence in stable, acapsular mutants of cryptococcus neoformans.

Authors:  R A Fromtling; H J Shadomy; E S Jacobson
Journal:  Mycopathologia       Date:  1982-07-23       Impact factor: 2.574

9.  Rapid genetic identification and mapping of enzymatically amplified ribosomal DNA from several Cryptococcus species.

Authors:  R Vilgalys; M Hester
Journal:  J Bacteriol       Date:  1990-08       Impact factor: 3.490

10.  A placebo-controlled trial of maintenance therapy with fluconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome. California Collaborative Treatment Group.

Authors:  S A Bozzette; R A Larsen; J Chiu; M A Leal; J Jacobsen; P Rothman; P Robinson; G Gilbert; J A McCutchan; J Tilles
Journal:  N Engl J Med       Date:  1991-02-28       Impact factor: 91.245

View more
  60 in total

1.  Comparison of the roles of calcineurin in physiology and virulence in serotype D and serotype A strains of Cryptococcus neoformans.

Authors:  M C Cruz; R A Sia; M Olson; G M Cox; J Heitman
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

Review 2.  Strategies for the identification of virulence determinants in human pathogenic fungi.

Authors:  R Alonso-Monge; F Navarro-García; E Román; B Eisman; C Nombela; J Pla
Journal:  Curr Genet       Date:  2003-02-08       Impact factor: 3.886

Review 3.  Life and death in a macrophage: role of the glyoxylate cycle in virulence.

Authors:  Michael C Lorenz; Gerald R Fink
Journal:  Eukaryot Cell       Date:  2002-10

4.  Urease as a virulence factor in experimental cryptococcosis.

Authors:  G M Cox; J Mukherjee; G T Cole; A Casadevall; J R Perfect
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

5.  The G-protein beta subunit GPB1 is required for mating and haploid fruiting in Cryptococcus neoformans.

Authors:  P Wang; J R Perfect; J Heitman
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

6.  Loss of cell wall alpha(1-3) glucan affects Cryptococcus neoformans from ultrastructure to virulence.

Authors:  Amy J Reese; Aki Yoneda; Julia A Breger; Anne Beauvais; Hong Liu; Cara L Griffith; Indrani Bose; Myoung-Ju Kim; Colleen Skau; Sarah Yang; Julianne A Sefko; Masako Osumi; Jean-Paul Latge; Eleftherios Mylonakis; Tamara L Doering
Journal:  Mol Microbiol       Date:  2007-03       Impact factor: 3.501

7.  Development of Saccharomyces cerevisiae as a model pathogen. A system for the genetic identification of gene products required for survival in the mammalian host environment.

Authors:  A L Goldstein; J H McCusker
Journal:  Genetics       Date:  2001-10       Impact factor: 4.562

8.  Three galactose inducible promoters for use in C. neoformans var. grubii.

Authors:  Jack A Ruff; Jennifer K Lodge; Lorina G Baker
Journal:  Fungal Genet Biol       Date:  2008-10-14       Impact factor: 3.495

9.  Quantitation of Purines from Pigeon Guano and Implications for Cryptococcus neoformans Survival During Infection.

Authors:  Jessica L Chitty; David J Edwards; Avril A B Robertson; Mark S Butler; John A Duley; Matthew A Cooper; James A Fraser
Journal:  Mycopathologia       Date:  2019-02-01       Impact factor: 2.574

10.  Relationship of the glyoxylate pathway to the pathogenesis of Cryptococcus neoformans.

Authors:  Thomas H Rude; Dena L Toffaletti; Gary M Cox; John R Perfect
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.